\changetocdepth {2}
\babel@toc {english}{}\relax 
\contentsline {chapter}{\chapternumberline {1}Introduction}{1}{chapter.1}%
\contentsline {section}{\numberline {1.1}Motivation}{2}{section.1.1}%
\contentsline {section}{\numberline {1.2}An Introduction to RNA-seq}{2}{section.1.2}%
\contentsline {section}{\numberline {1.3}Aim and Objectives}{5}{section.1.3}%
\contentsline {section}{\numberline {1.4}Our Approach}{5}{section.1.4}%
\contentsline {section}{\numberline {1.5}Document Structure}{6}{section.1.5}%
\contentsline {chapter}{\chapternumberline {2}Background \& Literature Overview}{9}{chapter.2}%
\contentsline {section}{\numberline {2.1}Acute Myeloid Leukaemia}{10}{section.2.1}%
\contentsline {subsection}{\numberline {2.1.1}Classification and Subtypes}{11}{subsection.2.1.1}%
\contentsline {subsubsection}{\numberline {2.1.1.1}The FAB classification system}{11}{subsubsection.2.1.1.1}%
\contentsline {subsubsection}{\numberline {2.1.1.2}The WHO classification system}{11}{subsubsection.2.1.1.2}%
\contentsline {subsection}{\numberline {2.1.2}Pathogenesis}{12}{subsection.2.1.2}%
\contentsline {subsubsection}{\numberline {2.1.2.1}Cytogenic Abnormalities}{12}{subsubsection.2.1.2.1}%
\contentsline {subsubsection}{\numberline {2.1.2.2}Genetic Abnormalities}{14}{subsubsection.2.1.2.2}%
\contentsline {subsection}{\numberline {2.1.3} Treatment Methods}{15}{subsection.2.1.3}%
\contentsline {subsection}{\numberline {2.1.4}The Model Cell Line: HL-60 }{16}{subsection.2.1.4}%
\contentsline {section}{\numberline {2.2}RNA-seq: \textit {in vitro}}{18}{section.2.2}%
\contentsline {subsection}{\numberline {2.2.1}Experimental Design}{18}{subsection.2.2.1}%
\contentsline {subsection}{\numberline {2.2.2}RNA extraction}{20}{subsection.2.2.2}%
\contentsline {subsection}{\numberline {2.2.3}Library Preparation}{21}{subsection.2.2.3}%
\contentsline {subsection}{\numberline {2.2.4}Clonal amplification}{21}{subsection.2.2.4}%
\contentsline {subsection}{\numberline {2.2.5}Sequencing and Nucleobase Detection}{22}{subsection.2.2.5}%
\contentsline {section}{\numberline {2.3}RNA-seq: \textit {in silico}}{25}{section.2.3}%
\contentsline {subsection}{\numberline {2.3.1}Quality Control}{25}{subsection.2.3.1}%
\contentsline {subsubsection}{\numberline {2.3.1.1}FastQC}{26}{subsubsection.2.3.1.1}%
\contentsline {subsubsection}{\numberline {2.3.1.2}FastQScreen}{27}{subsubsection.2.3.1.2}%
\contentsline {subsubsection}{\numberline {2.3.1.3}MultiQC}{28}{subsubsection.2.3.1.3}%
\contentsline {subsection}{\numberline {2.3.2}Preprocessing}{28}{subsection.2.3.2}%
\contentsline {subsubsection}{\numberline {2.3.2.1}Cutadapt: Short reads and Adapter sequences}{28}{subsubsection.2.3.2.1}%
\contentsline {subsubsection}{\numberline {2.3.2.2}Prinseq++: Low complexity and No Basecalls}{29}{subsubsection.2.3.2.2}%
\contentsline {subsection}{\numberline {2.3.3}Alignment}{30}{subsection.2.3.3}%
\contentsline {subsubsection}{\numberline {2.3.3.1}STAR}{32}{subsubsection.2.3.3.1}%
\contentsline {subsection}{\numberline {2.3.4}Quantification}{33}{subsection.2.3.4}%
\contentsline {subsubsection}{\numberline {2.3.4.1}RSEM}{33}{subsubsection.2.3.4.1}%
\contentsline {subsection}{\numberline {2.3.5}Normalisation}{34}{subsection.2.3.5}%
\contentsline {subsubsection}{\numberline {2.3.5.1}Trimmed Mean of \textit {M}-values (TMM)}{35}{subsubsection.2.3.5.1}%
\contentsline {subsection}{\numberline {2.3.6}Differential Expression Analysis}{36}{subsection.2.3.6}%
\contentsline {subsubsection}{\numberline {2.3.6.1}EdgeR}{37}{subsubsection.2.3.6.1}%
\contentsline {subsection}{\numberline {2.3.7}Downstream Analysis}{39}{subsection.2.3.7}%
\contentsline {subsubsection}{\numberline {2.3.7.1}Graphical Representation}{39}{subsubsection.2.3.7.1}%
\contentsline {subsubsection}{\numberline {2.3.7.2}Annotation and Enrichment Analyses}{40}{subsubsection.2.3.7.2}%
\contentsline {subsubsection}{\numberline {2.3.7.3}GAGE and Pathview}{41}{subsubsection.2.3.7.3}%
\contentsline {section}{\numberline {2.4}Evaluation Criteria}{42}{section.2.4}%
\contentsline {section}{\numberline {2.5}Related Work}{43}{section.2.5}%
\contentsline {subsection}{\numberline {2.5.1}Biochemistry of Olive Oil}{43}{subsection.2.5.1}%
\contentsline {subsection}{\numberline {2.5.2}Differentiation of HL-60 cells by Phenolic Compounds Derived from Olive Oil}{44}{subsection.2.5.2}%
\contentsline {subsection}{\numberline {2.5.3}A Review of the Computational Tools}{45}{subsection.2.5.3}%
\contentsline {section}{\numberline {2.6}Summary}{50}{section.2.6}%
\contentsline {chapter}{\chapternumberline {3}Methodology}{51}{chapter.3}%
\contentsline {section}{\numberline {3.1}Preceding Study: Origins of the Data}{51}{section.3.1}%
\contentsline {subsection}{\numberline {3.1.1}Phenolic extraction}{51}{subsection.3.1.1}%
\contentsline {subsection}{\numberline {3.1.2}Cell Culturing and RNA extraction}{52}{subsection.3.1.2}%
\contentsline {subsection}{\numberline {3.1.3}Determination of RNA Quality and Sequencing}{52}{subsection.3.1.3}%
\contentsline {section}{\numberline {3.2}RNA-seq Pipeline}{53}{section.3.2}%
\contentsline {subsection}{\numberline {3.2.1}Assessing the Quality of the Raw Data}{55}{subsection.3.2.1}%
\contentsline {subsection}{\numberline {3.2.2}Preprocessing}{55}{subsection.3.2.2}%
\contentsline {subsection}{\numberline {3.2.3}Read alignment and Quantification}{56}{subsection.3.2.3}%
\contentsline {subsection}{\numberline {3.2.4}Reassessing Data Quality}{58}{subsection.3.2.4}%
\contentsline {subsection}{\numberline {3.2.5}Normalisation and Differential Gene Expression}{58}{subsection.3.2.5}%
\contentsline {subsubsection}{\numberline {3.2.5.1}Filtering Low Count Genes}{59}{subsubsection.3.2.5.1}%
\contentsline {subsubsection}{\numberline {3.2.5.2}Gene Annotation}{59}{subsubsection.3.2.5.2}%
\contentsline {subsubsection}{\numberline {3.2.5.3}Normalisation}{60}{subsubsection.3.2.5.3}%
\contentsline {subsubsection}{\numberline {3.2.5.4}Adjusting p-values and Cut-offs}{60}{subsubsection.3.2.5.4}%
\contentsline {subsection}{\numberline {3.2.6}Gene Set Enrichment Analysis}{61}{subsection.3.2.6}%
\contentsline {section}{\numberline {3.3}Summary}{61}{section.3.3}%
\contentsline {chapter}{\chapternumberline {4}Results \& Discussion}{63}{chapter.4}%
\contentsline {section}{\numberline {4.1}Determining the Optimal Tools}{63}{section.4.1}%
\contentsline {subsection}{\numberline {4.1.1}Adapting DGE Analysis to a Lack of Replicates}{64}{subsection.4.1.1}%
\contentsline {section}{\numberline {4.2}Quality Control}{66}{section.4.2}%
\contentsline {subsection}{\numberline {4.2.1}Assessing the Quality of the Raw Data}{66}{subsection.4.2.1}%
\contentsline {subsection}{\numberline {4.2.2}Preprocessing}{74}{subsection.4.2.2}%
\contentsline {subsection}{\numberline {4.2.3}Read Alignment}{75}{subsection.4.2.3}%
\contentsline {subsection}{\numberline {4.2.4}QC Summary}{77}{subsection.4.2.4}%
\contentsline {section}{\numberline {4.3}Differential Gene Expression Analysis}{77}{section.4.3}%
\contentsline {subsection}{\numberline {4.3.1}Gene Set Enrichment Analysis}{77}{subsection.4.3.1}%
\contentsline {section}{\numberline {4.4}Summary}{77}{section.4.4}%
\contentsline {chapter}{References}{79}{chapter*.54}%
